Back to trial details

Intake questionnaire

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Applying to Emory University/Winship Cancer Institute · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Lung Non-Small Cell Carcinoma?
3. Are you able to travel to Atlanta for study visits?